UK markets open in 5 hours 4 minutes
NIKKEI 225
38,674.71 -272.22 (-0.70%) HANG SENG
19,155.37 -65.25 (-0.34%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,424.60 -1.30 (-0.05%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
55,115.98 -735.52 (-1.32%)
Wilmar International Ltd (RTHA.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 08:11AM CEST
| Previous close | 2.1050 |
| Open | 2.1110 |
| Bid | 2.1310 x 600000 |
| Ask | 2.1920 x 600000 |
| Day's range | 2.1110 - 2.1110 |
| 52-week range | 2.1050 - 2.7750 |
| Volume | |
| Avg. volume | 470 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Cerecin forges strategic partnership with A*STAR's Institute of Molecular and Cell Biology (IMCB) in Singapore to advance R&D in neurological disorders.
Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, is pleased to announce the establishment of a Memorandum of Understanding (MOU) with A*STAR's Institute of Molecular and Cell Biology (IMCB). This collaboration aims to accelerate research and treatment initiatives for neurological disorders and diseases to enhance overall health and brain function.
© 2024 Yahoo. All rights reserved.